Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 250

1.

Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.

Fingleton B, Carter KJ, Matrisian LM.

Cancer Res. 2007 May 15;67(10):4800-6.

PMID:
17510409
[PubMed - indexed for MEDLINE]
Free Article
2.

Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.

Ryan AE, Shanahan F, O'Connell J, Houston AM.

Cancer Res. 2005 Nov 1;65(21):9817-23.

PMID:
16267003
[PubMed - indexed for MEDLINE]
Free Article
3.

Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.

Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.

J Immunol. 1999 Jun 15;162(12):7350-7.

PMID:
10358186
[PubMed - indexed for MEDLINE]
Free Article
4.

Fas ligand promotes tumor immune evasion of colon cancer in vivo.

Ryan AE, Shanahan F, O'Connell J, Houston AM.

Cell Cycle. 2006 Feb;5(3):246-9. Epub 2006 Feb 14.

PMID:
16418579
[PubMed - indexed for MEDLINE]
Free Article
5.

Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.

Sieber OM, Howarth KM, Thirlwell C, Rowan A, Mandir N, Goodlad RA, Gilkar A, Spencer-Dene B, Stamp G, Johnson V, Silver A, Yang H, Miller JH, Ilyas M, Tomlinson IP.

Cancer Res. 2004 Dec 15;64(24):8876-81.

PMID:
15604247
[PubMed - indexed for MEDLINE]
Free Article
6.

Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.

Shimizu M, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.

Cancer Immunol Immunother. 1998 Nov;47(3):143-8.

PMID:
9829839
[PubMed - indexed for MEDLINE]
7.

The expression and role of Fas ligand in intestinal inflammation.

Sayani FA, Keenan CM, Van Sickle MD, Amundson KR, Parr EJ, Mathison RD, MacNaughton WK, Braun JE, Sharkey KA.

Neurogastroenterol Motil. 2004 Feb;16(1):61-74.

PMID:
14764206
[PubMed - indexed for MEDLINE]
8.

Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.

Fleck M, Zhang HG, Kern ER, Hsu HC, Müller-Ladner U, Mountz JD.

Arthritis Rheum. 2001 Apr;44(4):964-73.

PMID:
11315936
[PubMed - indexed for MEDLINE]
Free Article
9.

Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.

Pinkoski MJ, Droin NM, Lin T, Genestier L, Ferguson TA, Green DR.

Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16174-9. Epub 2002 Nov 26.

PMID:
12454289
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.

Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Lüscher TF.

Circulation. 2006 Apr 18;113(15):1879-87. Epub 2006 Apr 10.

PMID:
16606788
[PubMed - indexed for MEDLINE]
Free Article
11.

Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.

Kettunen HL, Kettunen AS, Rautonen NE.

Cancer Res. 2003 Aug 15;63(16):5136-42.

PMID:
12941845
[PubMed - indexed for MEDLINE]
Free Article
12.

Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.

Mann EA, Steinbrecher KA, Stroup C, Witte DP, Cohen MB, Giannella RA.

Int J Cancer. 2005 Sep 10;116(4):500-5.

PMID:
15825168
[PubMed - indexed for MEDLINE]
13.

Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.

Kobata T, Takasaki K, Asahara H, Hong NM, Masuko-Hongo K, Kato T, Hirose S, Shirai T, Kayagaki N, Yagita H, Okumura K, Nishioka K.

Immunology. 1997 Oct;92(2):206-13.

PMID:
9415028
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.

Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, et al.

Immunity. 1994 May;1(2):131-6.

PMID:
7889405
[PubMed - indexed for MEDLINE]
15.

Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.

Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE.

Cancer Res. 2006 Jan 1;66(1):57-61.

PMID:
16397216
[PubMed - indexed for MEDLINE]
Free Article
16.

Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.

Hsu HC, Zhang HG, Song GG, Xie J, Liu D, Yang PA, Fleck M, Wintersberger W, Zhou T, Edwards CK 3rd, Mountz JD.

Arthritis Rheum. 2001 Sep;44(9):2146-59.

PMID:
11592380
[PubMed - indexed for MEDLINE]
Free Article
17.

Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.

Yoshimoto Y, Kawada M, Ikeda D, Ishizuka M.

Int Immunopharmacol. 2005 Feb;5(2):281-8.

PMID:
15652759
[PubMed - indexed for MEDLINE]
18.

Characterization of the non-functional Fas ligand of gld mice.

Hahne M, Peitsch MC, Irmler M, Schröter M, Lowin B, Rousseau M, Bron C, Renno T, French L, Tschopp J.

Int Immunol. 1995 Sep;7(9):1381-6.

PMID:
7495745
[PubMed - indexed for MEDLINE]
19.

Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.

Omokaro SO, Desierto MJ, Eckhaus MA, Ellison FM, Chen J, Young NS.

J Immunol. 2009 Mar 15;182(6):3414-22. doi: 10.4049/jimmunol.0801430.

PMID:
19265119
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

TNF contributes to the immunopathology of perforin/Fas ligand double deficiency.

Cretney E, Street SE, Smyth MJ.

Immunol Cell Biol. 2002 Oct;80(5):436-40.

PMID:
12225379
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk